AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 65(6), 2001, pp. 717-721
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teja-Isavadharm, P
Right arrow Articles by Kyle, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teja-Isavadharm, P
Right arrow Articles by Kyle, D.
Related Collections
Right arrow Travel Medicine
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 6, 717-721
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria

P Teja-Isavadharm, G Watt, C Eamsila, K Jongsakul, Q Li, G Keeratithakul, N Sirisopana, L Luesutthiviboon, TG Brewer, and DE Kyle

The single-dose pharmacokinetics of 100 mg of orally administered artesunate (AS) were studied in 6 patient volunteers with uncomplicated falciparum malaria and in 6 healthy volunteers. Plasma concentrations of both the parent drug, AS, and its major metabolite, dihydroartemisinin (DHA), were measured simultaneously by high-performance liquid chromatography (HPLC) with electrochemical detection (ECD). The antimalarial activity of each plasma sample measured by an in vitro bioassay (BA) was used to derive activity concentrations. Artesunate was absorbed rapidly and then almost completely hydrolyzed to DHA in patients, whereas hydrolysis was incomplete in healthy volunteers. The mean +/- standard deviation (SD) maximum concentration (Cmax) of AS was 296+/-110 nmol/L, the time to peak blood level (tmax was 0.71+/-0.66 hr, the half-life (t1/2,z) was 0.41+/-0.34 hr, and the bioavailability over 12 hr (area under the curve [AUC](0-12)) was 253+/-185 nmol hr/L. Measured by HPLC, the Cmax and AUC(0-12) values of DHA in patients with malaria were significantly greater than in volunteers (1,948+/-772 and 1,192+/-315 nmol/L; 4,024+/-1,585 and 1,763+/-607 nmol hr/L, respectively; P < or = 0.05). These differences were even greater when measured by BA. The Cmax for patients with malaria was 2,894+/-2,497 and 795+/-455 nmol/L for volunteers, and AUC(0-12) was 5,970+/-3,625 and 1,307+/-391 nmol hr/L, respectively (P < or = 0.05). In contrast, DHA parameter estimates for t1/2,z and tmax were similar between patients and healthy volunteers, with values of 0.80+/-0.30 versus 0.87+/-0.06 hr and 1.50+/-0.55 versus 1.13+/-0.52 hr, respectively (P > 0.5). Both drug metabolism and tissue protein binding could contribute to the differences between the antimalarial activity of artemisinin drugs in healthy volunteers and malaria infected patients.


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
V. Sinou, N. Taudon, J. Mosnier, C. Aglioni, F. M. M. Bressolle, and D. Parzy
Pharmacokinetics of artesunate in the domestic pig
J. Antimicrob. Chemother., September 1, 2008; 62(3): 566 - 574.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. Nagelschmitz, B. Voith, G. Wensing, A. Roemer, B. Fugmann, R. K. Haynes, B. M. Kotecka, K. H. Rieckmann, and M. D. Edstein
First Assessment in Humans of the Safety, Tolerability, Pharmacokinetics, and Ex Vivo Pharmacodynamic Antimalarial Activity of the New Artemisinin Derivative Artemisone
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3085 - 3091.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
F. Nosten and N. J. White
Artemisinin-Based Combination Treatment of Falciparum Malaria
Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 181 - 192.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. P. ALKER, P. LIM, R. SEM, N. K. SHAH, P. YI, D. M. BOUTH, R. TSUYUOKA, J. D. MAGUIRE, T. FANDEUR, F. ARIEY, et al.
PFMDR1 AND IN VIVO RESISTANCE TO ARTESUNATE-MEFLOQUINE IN FALCIPARUM MALARIA ON THE CAMBODIAN-THAI BORDER
Am J Trop Med Hyg, April 1, 2007; 76(4): 641 - 647.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
C J Woodrow, R K Haynes, and S Krishna
Artemisinins
Postgrad. Med. J., February 1, 2005; 81(952): 71 - 78.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
H. Noedl, P. Teja-Isavadharm, and R. S. Miller
Nonisotopic, Semiautomated Plasmodium falciparum Bioassay for Measurement of Antimalarial Drug Levels in Serum or Plasma
Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4485 - 4487.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. Teja-Isavadharm, J. O. Peggins, T. G. Brewer, N. J. White, H. K. Webster, and D. E. Kyle
Plasmodium falciparum-Based Bioassay for Measurement of Artemisinin Derivatives in Plasma or Serum
Antimicrob. Agents Chemother., March 1, 2004; 48(3): 954 - 960.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. I. AWAD, A. M. Y. ALKADRU, R. H. BEHRENS, O. Z. BARAKA, and I. B. ELTAYEB
DESCRIPTIVE STUDY ON THE EFFICACY AND SAFETY OF ARTESUNATE SUPPOSITORY IN COMBINATION WITH OTHER ANTIMALARIALS IN THE TREATMENT OF SEVERE MALARIA IN SUDAN
Am J Trop Med Hyg, February 1, 2003; 68(2): 153 - 158.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.